Halo phenomenon with regression of acquired melanocytic nevi: A case report

Acta Dermatovenerologica Croatica

Volumn 17, Issue 2, 2009, Pages 139-143

  Radoš, Jaka ^a   Paštar, Zrinjka ^a   Lipozenčić, Jasna ^a   Ilić, Ivana ^a   Buzina, Daška Štulhofer ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

Halo nevus; Halo phenomenon; Regression of nevi

Indexed keywords

ADULT; ARTICLE; CASE REPORT; EPILUMINESCENCE MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNITY; MELANOCYTE; MELANOCYTIC NEVUS; STAINING;

DERMOSCOPY; FEMALE; HUMANS; NEVUS, HALO; NEVUS, PIGMENTED; SKIN NEOPLASMS; YOUNG ADULT;

EID: 68149165371     PISSN: 1330027X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. rd ed. Boston: Elsevier Mosby; 2005. pp.1266-8.
2. nd ed. Edinburgh, London, New York, Oxford, Philadelphia, St. Louis, Sydney, Toronto: Churchill Livingstone; 2002. pp. 810-1.
3. Mooney MA, Barr RJ, Buxton MGM. Halo nevus or halo phenomenon? A study of 142 cases. J Cutan Pathol 1995;22:342-8.
4. Harvell JD, Meehan SA, LeBoit PE. Spitz's nevi with halo reaction: a histopathologic study of 17 cases. J Cutan Pathol 1997;24:611-9.
5. Herd RM, Hunter JA. Familial halo nevi. Clin Exp Dermatol 1998;23:68-9.
6. Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB. Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Arch Dermatol 1982;118:34-6.
7. Zeff RA, Freitag A, Grin CM, Grant-Kels JM. The immune response in halo nevi. J Am Acad Dermatol 1997;37:620-4.
8. Bayer-Garner IB, Ivan D, Schwartz MR, Tschen JA. The immunopathology of regression in benign lichenoid keratosis, keratoacanthoma and halo nevus. Clin Med Res 2004;2:89-97.
9. Hoffman-Wellenhof R, Wolf P, Smolle J, Reimann-Weber A, Soyer HP, Kerl H. Influence of UVB therapy on dermoscopic features of acquired melanocytic nevi. J Am Acad Dermatol 1997;37:559-63.
10. Pharis DB, Zitelli JA. Sunburn, trauma, and the timing of biopsies of melanocytic nevi. Dermatol Surg 2001;27:835-6.
11. Bennett C, Copeman PW. Melanocyte mutation in halo naevus and malignant melanoma? Br J Dermatol 1979;100:423-6.
12. Cooke KB, Bennett C, Staughton RC. Melanoma specific protein: occurrence in the urine of patients with halo naevus and vitiligo. Br J Dermatol 1978;98:663-8.
13. De Vijlder HC, Westerhof W, Schreuder GMTH, de Lange P, Claas FHJ. Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res 2004;17:270-4.
14. Brandt O, Cristophers E, Fölster-Holst R. Halo dermatitis followed by the development of vitiligo associated with Sutton's nevi. J Am Acad Dermatol 2005;52:S101-4.
15. Kolm I, Di Stefani A, Hofmann-Wellenhof R, Fink-Puches R, Wolf IH, et al. Dermoscopy patterns of halo nevi. Arch Dermatol 2006;142:1627-32.
16. Pizzichetta MA, Talamini R, Stanganelli I, Puddu P, Bono R, Argenziano G, Veronesi A, Trevisan G, Rabinovitz H, Soyer P. Amelanotic/ hypomelanotic melanoma: clinical and dermoscopic features. Br J Dermatol 2004;150:1117-24.